B
B

Dividends • BridgeBio Oncology

BBOT

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

See below the complete and updated table with all dividends paid and declared history, etc

This company has not yet paid dividends.